Αποτελέσματα Αναζήτησης
Charter Life Sciences (CLS) operates as a venture capital firm. The Company focuses on the early stage clinical life science companies such as medical device and drug development...
17 Ιουλ 2024 · Charter Life Sciences - US focused early-stage VC firm. Portfolio of 17 companies. 21 investors have invested with Charter Life Sciences. Team has 5 members.
Charter Life Sciences is a clinical stage life sciences venture capital investor. Use the CB Insights Platform to explore Charter Life Sciences's full profile.
10 Μαρ 2011 · He is a Managing Partner of Charter Life Sciences (CLS), a life science-focused venture capital fund. He served as the Chairman at Great Lakes Pharmaceuticals, Health Fidelity, and FloShield. Prior to founding CLS, he was the chief executive officer and then chairman of Heska (HSKA).
Charter Life Sciences is a clinical-stage venture capital firm focused on investments in early-stage opportunities.
Charter Life Sciences is a clinical-stage venture capital firm focused on investments in early-stage opportunities.
Charter Life Sciences has a portfolio of 17 companies. They have 8 portfolio exits.
